期刊
KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY
卷 13, 期 6, 页码 449-454出版社
KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY
DOI: 10.4196/kjpp.2009.13.6.449
关键词
AMP-activated protein kinase (AMPK); AMPK alpha 1 catalytic subunit; Adenovirus; Type 2 diabetes; OLETF; Fatty liver
资金
- Korean Government [KRF-2006-531-E00014, KRF-2006-005-J03503]
5'-AMP-activated protein kinase (AMPK) is a heterotrimeric complex consisting of a catalytic (alpha) and two regulatory (beta and gamma) subunits. Two isoforms are known for catalytic subunit (alpha 1, alpha 2) and are encoded by different genes. To assess the metabolic effects of AMPK alpha 1, we examined the effects of overexpression of adenoviral-mediated AMPK alpha 1 in hyperlipidemic type 2 diabetic rats. The Otsuka Long-Evans Tokushima Fatty (OLETF) rat is an established animal model of type 2 diabetes that exhibits chronic and slowly progressive hyperglycemia and hyperlipidemia. Thirty five-week-old overt type 2 diabetic rats (n=10) were administered intravenously with Ad.AMPK alpha 1. AMPK activity was measured by phosphorylation of acetyl CoA carboxlyase (ACC). To investigate the changes of gene expression related glucose and lipid metabolism, quantitative real-time PCR was performed with liver tissues. Overexpression of AMPK alpha 1 showed that blood glucose concentration was decreased but that glucose tolerance was not completely recovered on 7th day after treatment. Plasma triglyceride concentration was decreased slightly, and hepatic triglyceride content was markedly reduced by decreasing expression of hepatic lipogenic genes. Overexpression of AMPK alpha 1 markedly improved hepatic steatosis and it may have effective role for improving hepatic lipid metabolism in hyperlipidemic state.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据